| [1] |
Fitzmorris P, Shoreibah M, Anand BS, et al. Management of hepatocellular carcinoma[J]. J Cancer Res Clin Oncol, 2015, 141(5): 861-876.
|
| [2] |
Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008[J]. Int J Cancer, 2010, 127(12): 2893-2917.
|
| [3] |
Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016, 66(2):115-132.
|
| [4] |
Naugler WE, Sakurai T, Kim S, et al. Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production[J]. Science, 2007, 317(5834):121-124.
|
| [5] |
Croswell JM, Ransohoff DF, Kramer BS. Principles of cancer screening: lessons from history and study design issues[J]. Semin Oncol, 2010, 37(3):202-215.
|
| [6] |
Meirelles Júnior RF, Salvalaggio P, Rezende MB, et al. Liver transplantation: history, outcomes and perspectives[J]. Einstein, 2015, 13(1):149-152.
|
| [7] |
Starzl TE, Todo S, Tzakis AG, et al. Liver transplantation:an unfinished product[J]. Transplant Proc, 1989, 21(1 Pt 2):2197-2200.
|
| [8] |
Fung JJ, Todo S, Jain A, et al. Conversion from cyclosporine to FK 506 in liver allograft recipients with cyclosporine-related complications[J]. Transplant Proc, 1990, 22(1):6-12.
|
| [9] |
Makuuchi M, Sano K. The surgical approach to HCC: our progress and results in Japan[J]. Liver Transpl, 2004, 10(2 Suppl 1):S46-52.
|
| [10] |
Dodson RM, He J, Pawlik TM. Resection and transplantation for hepatocellular carcinoma: factors influencing surgical options[J]. Future Oncol, 2014, 10(4):587-607.
|
| [11] |
Herrero JI, Sangro B, Pardo F, et al. Liver transplantation in patients with hepatocellular carcinoma across Milan criteria[J]. Liver Transpl, 2008, 14(3):272-278.
|
| [12] |
Freeman RB, Edwards EB, Harper AM. Waiting list removal rates among patients with chronic and malignant liver diseases[J]. Am J Transplant, 2006, 6(6):1416-1421.
|
| [13] |
Washburn K, Edwards E, Harper A, et al. Hepatocellular carcinoma patients are advantaged in the current liver transplant allocation system[J]. Am J Transplant, 2010, 10(7):1643-1648.
|
| [14] |
Terrault NA, Shiffman ML, Lok AS, et al. Outcomes in hepatitis C virus-infected recipients of living donor vs. deceased donor liver transplantation[J]. Liver Transpl, 2007, 13(1):122-129.
|
| [15] |
Ghobrial RM, Freise CE, Trotter JF, et al. Donor morbidity after living donation for liver transplantation[J]. Gastroenterology, 2008, 135(2):468-476.
|
| [16] |
Loggi E, Micco L, Ercolani G, et al. Liver transplantation from hepatitis B surface antigen positive donors: a safe way to expand the donor pool[J]. J Hepatol, 2012, 56(3):579-585.
|
| [17] |
Jiang W, Li J, Guo Q, et al. Liver transplantation for hepatocellular carcinoma[J]. Drug Discov Ther, 2015, 9(5):331-334.
|
| [18] |
Majno P, Giostra E, Mentha G. Management of hepatocellular carcinoma on the waiting list before liver transplantation: time for controlled trials?[J]. Liver Transpl, 2007, 13(11 Suppl 2):S27-35.
|
| [19] |
Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease[J]. Hepatology, 2001, 33(2):464-470.
|
| [20] |
Freeman RB Jr, Wiesner RH, Harper A, et al. The new liver allocation system: moving toward evidence-based transplantation policy[J]. Liver Transpl, 2002, 8(9):851-858.
|